# Run review: `retinopathy-p0-20261101-2`

**Run date:** 1 November 2026. **Model:** local `qwen3:8b`.

The seven-stage default diabetic retinopathy drill completed with 31 decisions and one configured gap record. `make verify-log RUN=retinopathy-p0-20261101-2` verified its hash chain. `make audit-evidence RUN=retinopathy-p0-20261101-2` screened the log and found eight decisions with no citation and one remaining citation flagged for review. The decision entries contain 23 `PARTIALLY_SUPPORTED` and eight `INSUFFICIENT_EVIDENCE` statuses. `PARTIALLY_SUPPORTED` is a lexical and source-scope screening label, not a determination that the exact claim is supported.

The revised triage caught some weak citations and abstained from recording them. It did not resolve semantic citation quality. Examples visible in the run include a clinical patient-review rationale citing a UAE data-protection passage, a Dubai patient-follow-up rationale citing a data-exchange law passage, and a Swiss vendor secondary-use rationale citing the same FADP and MedDO pages flagged in the earlier run review. These need passage-level and mandate review before being used as policy evidence. The first screening operator also explained why its supplied citations did not support reporting a model update while still selecting that action; the audit recorded no citation for that decision.

The gap artifact is a scenario-configured candidate concerning evidence sharing and vigilance coordination. This run does not establish a legal or policy gap. The synthetic liaison action sent no message or patient data. The recorded clinical halt remains subject to human approval.

Verification performed: `.venv/bin/python -m pytest -q` (8 passed), `make verify-sources` (21 tracked hashes verified), run hash-chain verification (passed), and evidence audit (counts above). A manually reviewed citation-support benchmark and substantive source applicability review remain outstanding.
